IL6 and gastritis: We observed a significant dose-dependent decrease and increase in the levels of pro-inflammatory cytokine IL-6 and IFN-γ for DFMO-treated mice compared to untreated mice exhibiting gastritis and to H. pylori-eradicated mice (p < 0.0001; Figure 6c,d), respectively.